Last Funding Type: Post-IPO Equity
Total Funding: $249.5M
Funding Status: IPO
Number Of Exists: Post-IPO Equity
Employee Number: 51-100
Estimated Revenue: Less than $1M
Technology: P4 Medicine
Investors Number: 14
Founded Date: 2008
Headquarters: Oxton, York, United Kingdom
Investment Stage: N/A
Industry: Genomic and Epigenominc Instabillity
Investor Type: Company